Naprilene (Enalapril Maleate)

Enalapril is converted in the body to enalaprilat, which blocks the angiotensin‑converting enzyme (ACE). By inhibiting ACE, the drug reduces the formation of angiotensin II, a powerful vasoconstrictor, leading to vessel relaxation, lower blood pressure, decreased aldosterone release, and reduced sodium and water retention.

The appropriate dose of Naprilene is individualized and set by the prescribing clinician based on the patient’s condition, response, and renal function. Dosage may be started low and titrated upward, with regular monitoring to achieve therapeutic goals while minimizing side effects.

Naprilene is classified as Pregnancy Category D, indicating evidence of risk to the fetus, especially in the second and third trimesters, and it is generally contraindicated during pregnancy. Limited data exist for breastfeeding; the drug may pass into milk, so use is discouraged unless the benefit outweighs potential risk.

To order Naprilene, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Naprilene (enalapril) belongs to the ACE inhibitor class, which directly blocks the conversion of angiotensin I to angiotensin II. Compared with ARBs, ACE inhibitors also increase bradykinin levels, which can cause a dry cough but may offer additional vascular benefits. They are often preferred for heart‑failure patients due to proven mortality reduction.

Naprilene tablets should be stored at room temperature, below 25 °C, in their original container to protect from moisture and light. Keep the product out of reach of children and avoid storing in humid or excessively hot environments to maintain potency.

Naprilene is taken orally, usually once or twice daily as directed by a healthcare professional. It can be swallowed with or without food; however, taking it with a full glass of water helps ensure proper absorption. Patients should follow the prescriber’s instructions regarding timing and any dose adjustments.

The most serious risks include angioedema, which can cause life‑threatening swelling of the face or airway; severe hypotension, especially after the first dose; acute kidney injury, particularly in patients with pre‑existing renal disease; and hyperkalemia, which can lead to cardiac arrhythmias if potassium levels become too high.

Naprilene should be avoided in patients with a known history of angioedema related to ACE inhibitors, in those who are pregnant (especially after the first trimester), and in individuals with severe renal impairment or bilateral renal artery stenosis. Caution is also advised for patients with hyperkalemia or those taking potassium‑sparing diuretics.